1. Home
  2. NVAX vs EVH Comparison

NVAX vs EVH Comparison

Compare NVAX & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • EVH
  • Stock Information
  • Founded
  • NVAX 1987
  • EVH 2011
  • Country
  • NVAX United States
  • EVH United States
  • Employees
  • NVAX N/A
  • EVH N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • EVH Other Consumer Services
  • Sector
  • NVAX Health Care
  • EVH Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • EVH Nasdaq
  • Market Cap
  • NVAX 1.3B
  • EVH 1.2B
  • IPO Year
  • NVAX 1995
  • EVH 2015
  • Fundamental
  • Price
  • NVAX $8.17
  • EVH $9.55
  • Analyst Decision
  • NVAX Buy
  • EVH Strong Buy
  • Analyst Count
  • NVAX 6
  • EVH 14
  • Target Price
  • NVAX $17.83
  • EVH $16.71
  • AVG Volume (30 Days)
  • NVAX 4.7M
  • EVH 3.2M
  • Earning Date
  • NVAX 05-09-2025
  • EVH 05-08-2025
  • Dividend Yield
  • NVAX N/A
  • EVH N/A
  • EPS Growth
  • NVAX N/A
  • EVH N/A
  • EPS
  • NVAX N/A
  • EVH N/A
  • Revenue
  • NVAX $682,162,000.00
  • EVH $2,554,741,000.00
  • Revenue This Year
  • NVAX N/A
  • EVH N/A
  • Revenue Next Year
  • NVAX $15.02
  • EVH $15.02
  • P/E Ratio
  • NVAX N/A
  • EVH N/A
  • Revenue Growth
  • NVAX N/A
  • EVH 30.09
  • 52 Week Low
  • NVAX $3.81
  • EVH $8.35
  • 52 Week High
  • NVAX $23.86
  • EVH $33.80
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.30
  • EVH 48.16
  • Support Level
  • NVAX $7.66
  • EVH $8.35
  • Resistance Level
  • NVAX $8.48
  • EVH $9.75
  • Average True Range (ATR)
  • NVAX 0.64
  • EVH 0.64
  • MACD
  • NVAX 0.08
  • EVH 0.07
  • Stochastic Oscillator
  • NVAX 71.43
  • EVH 50.21

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Share on Social Networks: